Summary
The concurrence in recent years of mounting pressures to contain pharmaceutical expenditures in the United States and Europe, and rising research and development costs for new drugs, raises concerns about the future of new drug development. A recent study has shown that the research and development expenditures required to get new drugs to the marketplace are high and have been increasing rapidly. A random sample of 93 new chemical entities (NCEs) first tested in humans in 1970 to 1982 yielded an estimate for the cost per approved NCE of US$231 million in 1987 dollars. This estimate is more than double, in constant dollars, that of a previous study that used a similar methodology and covered a period roughly one decade earlier. The 2 studies were analysed to determine the components of the cost increase, and some of the more fruitful areas for future research on research and development costs are discussed.
Similar content being viewed by others
References
DiMasi JA, Hansen RW, Grabowski HG, Lasagna L. Cost of innovation in the pharmaceutical industry. Journal of Health Economics 10: 107–142, 1991
Grabowski HG, Vernon JM. A new look at the returns and risks to pharmaceutical R&D. Management Science 36: 804–821, 1990
Hansen RW. The pharmaceutical development process: estimates of current development costs and times and the effects of regulatory changes. In Chien RI (Ed.) Issues in pharmaceutical economics, pp. 151–187, Lexington Books, Lexington, 1979
Pharmaceutical Manufacturers Association. Annual survey report, Pharmaceutical Manufacturers Association, Washington, DC, 1968–1989
Wiggins SN. The cost of developing a new drug. Pharmaceutical Manufacturers Association, Washington, DC, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Di Masi, J.A. Rising Research and Development Costs for New Drugs in a Cost Containment Environment. Pharmacoeconomics 1 (Suppl 1), 13–20 (1992). https://doi.org/10.2165/00019053-199200011-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00019053-199200011-00006